Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous bone marrow-derived stem cells (MD Stem Cells)
- Development stage
- Unknown
- Lead developer
- MD Stem Cells
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intrathecal, Intranasal
01
Overview
Autologous bone marrow-derived stem cells (BMSC) developed by MD Stem Cells are a cell therapy intervention for the treatment of spinal cord injury (SCI). The process involves the extraction of bone marrow from the patient's iliac crest, followed by concentration of the cellular fraction—which includes mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs)—and subsequent re-injection into the patient via intravenous, intrathecal, or intranasal routes. The therapeutic rationale is based on the cells' ability to migrate to the site of injury, release neurotrophic factors, modulate the inflammatory response, and promote axonal sprouting or remyelination. In clinical trials, this biological treatment is often integrated with intensive physical therapy using robotic exoskeletons and virtual reality training to maximize functional neuro-rehabilitation.
- Other names
- BMSCBone Marrow Aspirate ConcentrateBMACautologous bone marrow-derived stem cells (MD Stem Cells)
Beyond the preview
Go deeper on autologous bone marrow-derived stem cells (MD Stem Cells).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous bone marrow-derived stem cells (MD Stem Cells).